WallStSmart
IGC

India Globalization Capital Inc

NYSE MKT: IGC · HEALTHCARE · BIOTECHNOLOGY

$0.32
+3.16% today

Updated 2026-04-30

Market cap
$31.63M
P/E ratio
P/S ratio
28.60x
EPS (TTM)
$-0.06
Dividend yield
52W range
$0 – $1
Volume
1.2M

WallStSmart proprietary scores

17
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
5.8
Quality
C+
2.5
Profitability
F
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$4.13
+1190.68%
12-Month target
Intrinsic (DCF)
Margin of safety
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-5.37M
- Revenue declining -53.60% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2023202420252026TTM
Revenue$911000.00$1.34M$1.27M$869000.00$1.11M
Net income$-11.51M$-13.00M$-7.12M$-4.15M$-4.15M
EPS$-0.06
Free cash flow$-7.67M$-5.71M$-5.28M$-5.37M$-5.37M
Profit margin-1,263.01%-966.54%-560.27%-477.10%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
IGC$31.63M172.72.55.05.8Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

India Globalization Capital Inc trades at $0.32. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $1.11M.

Frequently asked questions

What is India Globalization Capital Inc's stock price?
India Globalization Capital Inc (IGC) trades at $0.32.
Is India Globalization Capital Inc overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of India Globalization Capital Inc (IGC)?
The analyst target price is $4.13, representing +1190.7% upside from the current price of $0.32.
What is India Globalization Capital Inc's revenue?
TTM revenue is $1.11M.
Piotroski F-Score?
3/9 — weak financial health.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD

Quick metrics

P/S ratio28.60x
ROE-83.30%
Beta0.31
50D MA$0.29
200D MA$0.34
Shares out0.10B
Float0.08B
Short ratio
Avg volume1.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years